Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

35 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Familial hypercholesterolemia. Acceptor splice site (G-->C) mutation in intron 7 of the LDL-R gene: alternate RNA editing causes exon 8 skipping or a premature stop codon in exon 8. LDL-R(Honduras-1) [LDL-R1061(-1) G-->C].
Yu L, Heere-Ress E, Boucher B, Defesche JC, Kastelein J, Lavoie MA, Genest J Jr. Yu L, et al. Among authors: lavoie ma. Atherosclerosis. 1999 Sep;146(1):125-31. doi: 10.1016/s0021-9150(99)00109-4. Atherosclerosis. 1999. PMID: 10487495
Ezetimibe and cholesterol absorption.
Lavoie MA. Lavoie MA. Can J Clin Pharmacol. 2003 Winter;10 Suppl A:7A-12A. Can J Clin Pharmacol. 2003. PMID: 14571301 Review.
Effects of reconstituted high-density lipoprotein infusions on coronary atherosclerosis: a randomized controlled trial.
Tardif JC, Grégoire J, L'Allier PL, Ibrahim R, Lespérance J, Heinonen TM, Kouz S, Berry C, Basser R, Lavoie MA, Guertin MC, Rodés-Cabau J; Effect of rHDL on Atherosclerosis-Safety and Efficacy (ERASE) Investigators. Tardif JC, et al. Among authors: lavoie ma. JAMA. 2007 Apr 18;297(15):1675-82. doi: 10.1001/jama.297.15.jpc70004. Epub 2007 Mar 26. JAMA. 2007. PMID: 17387133 Clinical Trial.
Vascular protectants for the treatment of atherosclerosis.
Tardif JC, Grégoire J, Lavoie MA, L'Allier PL. Tardif JC, et al. Among authors: lavoie ma. Expert Rev Cardiovasc Ther. 2003 Sep;1(3):385-92. doi: 10.1586/14779072.1.3.385. Expert Rev Cardiovasc Ther. 2003. PMID: 15030266 Review.
Beneficial Effects of Reconstituted High-Density Lipoprotein (rHDL) on Circulating CD34+ Cells in Patients after an Acute Coronary Syndrome.
Gebhard C, Rhéaume E, Berry C, Brand G, Kernaleguen AE, Théberge-Julien G, Alam MA, Lee CY, Boileau L, Chabot-Blanchet M, Guertin MC, Lavoie MA, Grégoire J, Ibrahim R, L'Allier P, Tardif JC. Gebhard C, et al. Among authors: lavoie ma. PLoS One. 2017 Jan 6;12(1):e0168448. doi: 10.1371/journal.pone.0168448. eCollection 2017. PLoS One. 2017. PMID: 28060837 Free PMC article. Clinical Trial.
Baseline characteristics of patients with diabetes and coronary artery disease enrolled in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial.
Bypass Angioplasty Revascularization Investigation 2 Diabetes Study Group. Bypass Angioplasty Revascularization Investigation 2 Diabetes Study Group. Am Heart J. 2008 Sep;156(3):528-536, 536.e1-5. doi: 10.1016/j.ahj.2008.05.015. Epub 2008 Jul 31. Am Heart J. 2008. PMID: 18760137 Free PMC article. Clinical Trial.
35 results